Biosynthesis of angelyl-CoA in Saccharomyces cerevisiae

Microbial Cell Factories
Roberta CallariNora Weber

Abstract

The angelic acid moiety represents an essential modification in many biologically active products. These products are commonly known as angelates and several studies have demonstrated their therapeutic benefits, including anti-inflammatory and anti-cancer effects. However, their availability for use in the development of therapeutics is limited due to poor extraction yields. Chemical synthesis has been achieved but its complexity prevents application, therefore microbial production may offer a promising alternative. Here, we engineered the budding yeast Saccharomyces cerevisiae to produce angelyl-CoA, the CoA-activated form of angelic acid. For yeast-based production of angelyl-CoA we first expressed genes recently identified in the biosynthetic cluster ssf of Streptomyces sp. SF2575 in S. cerevisiae. Exogenous feeding of propionate and heterologous expression of a propionyl-CoA synthase from Streptomyces sp. were initially employed to increase the intracellular propionyl-CoA level, resulting in production of angelyl-CoA in the order of 5 mg/L. Substituting the Streptomyces sp. propionyl-CoA carboxylase with a carboxylase derived from Streptomyces coelicolor resulted in angelyl-CoA levels up to 6.4 mg/L. In vivo analysis allowe...Continue Reading

References

Mar 1, 1990·Journal of General Microbiology·C VerduynJ P van Dijken
Jul 3, 1995·Biochimica Et Biophysica Acta·W J ManD C Wilton
Jul 20, 1999·Microbiology·A R Horswill, J C Escalante-Semerena
May 23, 2000·Planta medica·J HohmannT Bartók
Jul 5, 2002·Nature·Philip Ball
Apr 17, 2003·FEMS Microbiology Reviews·J Kalervo HiltunenAner Gurvitz
Jul 22, 2004·European Journal of Biochemistry·Matthias Brock, Wolfgang Buckel
Jan 21, 2006·FEMS Yeast Research·Sarah C MutkaJames T Kealey
Apr 3, 2007·Nature Protocols·R Daniel Gietz, Robert H Schiestl
Nov 17, 2009·Journal of the American Chemical Society·Lauren B PickensYi Tang
Oct 20, 2010·Omics : a Journal of Integrative Biology·Nuno P MiraIsabel Sá-Correia
Apr 9, 2011·Journal of Natural Products·Hui-Zheng FuDong-Ming Zhang
May 16, 2012·Anti-cancer Agents in Medicinal Chemistry·Jinhui ZhangJunxuan Lü
Oct 23, 2012·ACS Chemical Biology·Irina KoryakinaGavin J Williams
Jan 2, 2013·Journal of Pharmaceutical and Biomedical Analysis·Ahmet Alper AydınThomas Letzel
Aug 3, 2013·Science·Lars JørgensenPhil S Baran
Apr 10, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Trine Bundgaard AndersenHenrik Toft Simonsen
Jun 18, 2016·Chembiochem : a European Journal of Chemical Biology·Yuki InahashiTakuji Nakashima
Aug 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Dan LuoBjörn Hamberger
Mar 3, 2018·ACS Synthetic Biology·Nicolas Krink-KoutsoubelisJay D Keasling

❮ Previous
Next ❯

Citations

Jan 5, 2021·Metabolic Engineering Communications·Young-Kyoung ParkJean-Marc Nicaud

❮ Previous
Next ❯

Datasets Mentioned

BETA
AAC44817.2

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.